In a genomic screen we isolated the Drosophila gene hugin (hug, cytology 87C1-2) by cross-hybridisation to a human glial cell linederived neurotrophic factor cDNA. Upon cDNA sequence analysis and in vitro expression assays, the hugin gene was found to encode a signal peptide containing proprotein that was further processed in Schneider-2 cells into peptides similar to known neuropeptides. Two of the peptides were similar to FXPRL-amides (pyrokinins) and to the ecdysis-triggering hormone, respectively. The former displayed myostimulatory activity in a bioassay on the cockroach hyperneural muscle preparation, as well as in the Drosophila heart muscle assay. Hugin is expressed during the later half of embryogenesis and during larval stages in a subgroup of neurosecretory cells of the suboesophageal ganglion. Ubiquitous ectopic hugin expression resulted in larval death predominantly at or shortly after ecdysis from second to third instar, suggesting that at least one of the posttranslational cleavage products affects molting of the larva by interfering with the regulation of ecdysis. q
Introduction
Ecdysis is the process through which insects shed their cuticle at the end of each molt. It consists of a series of stereotypic behaviour patterns, which are referred to as pre-ecdysis and ecdysis. The regulation of larval ecdysis by the neuropeptides eclosion hormone (EH), pre-ecdysis-triggering hormone (PETH), ecdysis-triggering hormone (ETH) and crustacean cardioactive peptide (CCAP) has been extensively studied in the tobacco hornworm, Manduca sexta and to some extent also in Drosophila. They are regulated throughout development by changes in the level of ecdysteroids in the hemolymph. Increasing ecdysteroid levels are required for apolysis and new cuticle formation at the end of each larval molt. High ecdysteroid levels also induce expression of PETH and ETH from the epitracheal glands as well as competence of EH-containing neurons in the central nervous system (CNS) to respond to these peptides. Declining ecdysteroid levels towards the end of the molt initiate, through a cascade of events, a positive feedback loop that eventually leads to a massive secretion of PETH, ETH and EH. During an early phase of this cycle, PETH and ETH induce pre-ecdysis, while EH-stimulated release of CCAP finally pushes the cycle towards ecdysis behaviour (Ewer et al., 1997; Truman, 1997, 1999; Kingan et al., 1997; Kingan and Adams, 2000; Ž itňan et al., 1996 .
In Drosophila, the genes encoding EH and ETHs were cloned (Horodyski et al., 1993; Park et al., 1999) , and the role of the corresponding peptides during ecdysis was analysed (Baker et al., 1999; McNabb et al., 1997; Park et al., 2002) . Ablation of EH-producing neurons causes larval semi-lethality and defects in adult eclosion behaviour (McNabb et al., 1997) . Mutants of the ETH gene, which lack Drm-ETH-1 and -2 are unsuccessful in performing the ecdysis behaviour and die at the first larval molt with a double mouthpart phenotype. The same effect is observed when Drm-ETH-1 is prematurely injected into wild-type larvae (Park et al., 2002) . This shows that a delicate balance of controlling neuropeptides is crucial for bringing the larva from one developmental stage to the next one.
Neuropeptides of the pyrokinin/pheromone biosynthesis activating neuropeptide (PBAN) family have been shown to be involved in several physiological activities such as pheromone biosynthesis, cuticular tanning, hindgut contraction or diapause induction (Gäde et al., 1997) . Among the identified Drosophila neuropeptide genes, only two have been suggested to encode myostimulatory peptides of this family (Choi et al., 2001 , Vanden Broeck, 2001 . In cockroaches and locusts, their number is quite high and it therefore seems that several remain to be found in Drosophila as well.
In this study, we describe the identification of the hugin gene, coding for neuropeptide players with myostimulatory and ecdysis modifying effects. The gene was identified in a screen for the most vertebrate glial cell line-derived neurotrophic factor (GDNF)-like sequences from Drosophila through classical low-stringency hybridisation. The hugin gene has coding capacity for at least two neuropeptides. One shows similarity to pyrokinins and the other to ecdysis-triggering hormone. Ectopic overexpression of the gene was found to disturb development at the level of larval molting in a pattern clearly reminiscent of ETH mutants (Park et al., 2002) .
Results

Cloning and cDNA sequence of hugin
Screening of a Drosophila genomic cosmid library at low stringency with a human GDNF cDNA probe followed by subcloning yielded a 1 kb EcoRI genomic fragment containing the most similar area. This fragment was used to probe a Northern blot and screen a cDNA library representing all stages of embryogenesis. A 1 kb-cDNA clone (pXM1-cDNA) was isolated and sequenced. A 4 kb genomic EcoRI-fragment upstream of the original 1 kb genomic fragment was also isolated and sequenced, allowing for the analysis of the gene structure. A canonical TATA-box and CAP-site were identified on the genomic sequence within 50 nucleotides upstream of the cDNA start (Fig. 1A) . This, together with the size of the transcript as identified on the Northern blot, were taken as bona fide indication that the cDNA was a full-length clone. The fly gene was named hugin and the sequence data entered into the EMBL database with the accession number AJ133105. The sequence analysis of the cDNA revealed the presence of a 573 bp coding sequence (CDS) (Fig. 1A) . The conceptual translation yields a 191-residue polypeptide with a predicted molecular weight of about 21 kDa with a signal sequence (amino acids 1-24) (Fig. 1B) .
hugin expression is restricted to the suboesophageal ganglion
A developmental Northern blot with total RNA from all developmental stages unveiled a transcript of 1 kb length.
The transcription of the hugin gene was detected during embryogenesis and persisted through adult stage. It was most abundant at the end of embryogenesis and during the first two larval stages ( Fig. 2A) . Whole mount in situ hybridisation to embryos and larvae from different developmental stages revealed expression of the gene starting at stage 9 in the suboesophageal ganglion in which it remains restricted for the whole of embryogenesis (Fig. 2B, C) , as well as in larvae (data not shown).
The hugin protein is cleaved in Schneider-2 cells to products similar to known neuropeptides
The Western blot analysis of conditioned media from S2 cells transfected with the fusion construct pMThugV5H6 using anti-V5 antibody revealed a pattern of small molecular size polypeptides, with the major bands having a molecular weight of about 5 and 8 kDa (Fig. 3) . Also, larger bands of about 18 and 23 kDa were visible. To identify the fragments, the C-terminally His-tagged secretion products were purified from the media and the strongest bands were isolated for N-terminal amino acid sequencing. The sequences obtained were SIDSWRLL and SVPFKPR, positioning the cleavage sites to the N-terminal side of serines 140 and 174 (Fig. 1B) . The calculated molecular weights of the proteolytic fragments including the C-terminal tags were 8.3 and 4.7 kDa, respectively, corresponding to the 8 and 5 kDa bands in the gel. The fainter 22 kDa band probably represents a small amount of unprocessed fusion protein without signal sequence (calculated weight 20.9 kDa). Also, a minor band of apparent weight of (C) Homology of hugin-derived hugg and Drm-PK-2 peptides to insect neuropeptides. The Drm-ETH-1 is from D. melanogaster (Q9U4J0), Lom-PK-2 from Locusta migratoria (P41488) and Pea-PK-3 from P. americana (P82618).
18 kDa was visible, positioning the N-terminus around 30-40 amino acids after the signal sequence cleavage site. Under non-reducing conditions multiple bands ranging in size between 8 and 43 kDa were seen, most likely representing the various hetero-and homodimers resulting from disulphide pairing of the processing intermediates via the cysteine at position 188.
Clusters of basic residues, which could act as targets for Drosophila pro-protein and pro-hormone convertases were found preceding the confirmed processing sites. Three additional putative convertase target sites, promoting cleavage after arginine residues 62, 120 and lysine 184, were identified (Fig. 1B) . Processing at R 62 would result in a 17.1 kDa C-terminal cleavage product, which could be responsible for the 18 kDa band in the Western blot. Cleavage at R 120 would create an intermediate peptide, which would be converted to an amidated form QLQSNGEPAYRVRTPRL-NH 2 (hugg) by the successive actions of carboxypeptidase E (encoded by silver) (Settle et al., 1995) , peptidylglycine-a-hydroxylating mono-oxygenase (PHM) and peptidyl a-hydroxyglycine-a-amidating lyase (PAL) (Kolhekar et al., 1997) . Another amidated peptide SVPFKPRL-NH 2 would result by cleavage at the sites K 173 and R 184 .
To verify the presence of the convertases in S2 cell line, we performed reverse transcriptase-polymerase chain reaction (RT-PCR) analysis with Fur1-and Fur2-specific primers. Both Fur1 (isoform not analysed) and Fur2 mRNA, were expressed in S2 cells (data not shown).
The obviously convertase-dependent cleavage of the hugin precursor was restricted to the S2 cell line, indicating a specificity of hugin processing. Overexpression of hugin in COS7 cells resulted in a major secretion product of the predicted size of full-length hugin after signal sequence removal (data not shown). The lack of processing in COS7 cells either reflects the low amounts of furins in this cell line (Shapiro et al., 1997) or the inability of mammalian convertases to recognise the processing motifs in the hugin precursor.
One of the hugin peptides, SVPFKPRL-NH 2 , was found to be similar to the recently identified pyrokinin 3 (Pea-PK-3) from the American cockroach, P. americana (Predel et al., 1999b) (Fig. 1C) . The Drosophila peptide contains the FXPRL-amide structure common to all known pyrokinins and was named Drm-PK-2. The longer peptide, tentatively named hugg has the same C-terminal PRL-amide designation, but lacks the preceding phenylalanine. The highest similarity scores were obtained with another Drosophila peptide, the ecdysis-triggering hormone 1 (Drm-ETH-1) encoded by the gene ETH (Park et al., 1999) .
Drm-PK-2 has pyrokinin activity in a muscle bioassay
Both putative peptides, Drm-PK-2 and hugg, were consecutively tested on the same hyperneural muscle preparations. Threshold values for myostimulatory effects of the peptides differed clearly. The hugg peptide exhibited a very low potency; Drm-PK-2 had a threshold concentration of about 3 £ 10 28 M, thus being slightly less active than the sequencerelated pyrokinin Pea-PK-3 (Fig. 4A ). The response of Drosophila heart preparations to Drm-PK-2 was a moderate increase in frequency not exceeding 150% of the control, even if the concentration was as high as 10 26 M (threshold at about 10 29 M). On the other hand, most preparations showed a clear increase in amplitude after pyrokinin application with a threshold as low as 3 £ 10 210 M (Fig. 4B ). These results show that Drm-PK-2 has pyrokinin activity.
Ectopic hugin expression reduces viability and causes larval death at ecdysis
Out of several tested GAL4-drivers, two caused a marked reduction in the number of eclosed adults. These lines expressed GAL4 either under the ubiquitous tubulin or under a neuroblast-specific promoter. All the flies that had experienced ectopic hugin expression during development, were slightly smaller in size than the controls, otherwise they looked normal. In order to determine the lethal phase, eggs were collected, the number of hatchings was counted, and the development of the larvae was followed until pupariation. No significant differences in the hatching frequencies were noticed between any of the experimental and control crosses (data not shown). Thus, the embryogenesis seems to proceed normally in the presence of ectopic hugin.
During larval development, the highest lethality was observed in larvae with the genotype UAS-hugin 8;tubP-GAL4, which carry two UAS-hugin insertions. Only 5% of the larvae survived until pupariation. The most prominent lethal phase, where 44% of all the larvae died, was around the second larval molt. Quite a few variations were observed between individuals in the precise time of death during the process. Earliest death was observed before the onset of ecdysis, when only duplicated mouth hooks and anterior spiracles were visible (Fig. 5A) . The most advanced larvae had developed two complete cephalopharyngeal skeletons and almost completed ecdysis before dying, partly surrounded by the old cuticle (Fig. 5B) .
In addition to the larvae, which simply arrested development, many exhibited defects in morphology and molting behaviour. Two major phenomena were observed: first, larvae that had shed the old cuticle (partly or completely), but that were still attached to the old cephalopharyngeal skeleton were observed (Fig. 5C) . This phenotype appears to be identical to the buttoned-up phenotype described by Park et al. (2002) , who could induce it either by deletion of the ETH gene, or by premature injection of Drm-ETH-1. Normally, wild-type larvae always start the ecdysis process by shedding the cephalopharyngeal skeleton (Park et al., 2002) . Second, the larvae often developed brown spots on the new cuticle in a regular pattern late during the second instar (Fig. 5A, B and D) . The heavily pigmented ones appeared unable to break the old second instar cuticle, although the cuticle with attached spiracles detached from the pigmented third instar cuticle. Instead, the larvae became trapped within a bag of old cuticle, in which they remained alive for some time (Fig. 5D ). Some of these trapped larvae still had not developed a complete new set of the cephalopharyngeal skeleton. To our knowledge, this phenomenon constitutes a novel phenotype. Of the larvae that survived through ecdysis, the majority (34% of all The response of semi-isolated Drosophila heart preparations to Drm-PK-2. Usually, peptide applications increased the amplitude. This effect was accompanied by a moderate increase of heart beat frequency (i). Sometimes only changes in the frequency could be observed (ii).
hatched larvae) died early during third instar. Taken together, these data suggest that ectopic hugin expression results in induction of premature ecdysis behaviour, which causes the death of the larva.
Discussion
The hugin gene was cloned from Drosophila serendipitously based on its limited sequence similarity to the human GDNF sequence. No conclusive sequence-based evidence for a functional similarity to the neurotrophic factor was found.
Hugin is a neuropeptide precursor
Segments of the conceptual hugin polypeptide showed similarity to neuropeptides. Neuropeptides are synthesised as inactive precursors, which after cleavage of the signal peptide, are further processed into the active substances through limited proteolytic cleavage and amidation (reviewed in Eipper et al., 1992) . Proteolytic processing of precursor molecules occurs predominantly at basic amino acid residues. Cleavage is achieved by members of the proprotein convertase (PC) family of evolutionary conserved serine proteases. Known PCs involved in Drosophila neuropeptide activation are Furin1, Furin2 and amontillado (De Bie et al., 1995; Siekhaus and Fuller, 1999) . Rules have been proposed in order to predict which putative proteolytic processing sites are actually used in insects (Veenstra, 2001 ). However, neuropeptides are generally short and do not allow straightforward authoritative database searching, even when the processing rules are known.
The expression of the hugin precursor in a Drosophila S2 cell line resulted in extensive post-translational processing with a pattern typical of the prohormone convertase substrates (De Bie et al., 1995; Roebroek et al., 1995) . We detected multiple processing intermediates, probably resulting from the high expression levels of the precursor. The differences in the cleavage efficiencies at the processing sites explain the variable amounts of tagged peptides of different sizes. Correct processing of the Drosophila proteins decapentaplegic and 60A at predicted pro-hormone convertase sites in S2 cells has been demonstrated (Sampath et al., 1993) . Our own RT-PCR results showed that furins, which are expressed in vivo at the site of hugin expression, the suboesophageal ganglion , are also endogenously expressed in S2 cells. This suggests that processing of the hugin precursors in this cell line reflects their processing in vivo.
Two endoproteolytic cleavage sites of the hugin precursor used in S2 cells were determined by amino acid sequencing of the processing products (Fig. 1B) . One of the peptides shares extensive similarity with pyrokinin Pea-PK-3 from P. americana (Predel et al., 1999b) , including the invariant FXPRL-amide motif present in all pyrokinins and is, therefore, here referred to as Drm-PK-2. Pyrokinins have earlier been isolated from cockroaches (Holman et al., 1986; Predel et al., 1999b) , locusts (Schoofs et al., 1993; Veelaert et al., 1997) and from the white shrimp Penaeus vannamei (Torfs et al., 2001) . However, the genes encoding the precursors of these peptides have not been identified. Previous in silico analyses of the Drosophila genome have uncovered one additional gene, capability (capa), with the potential to encode a pyrokinin peptide (Hewes and Taghert, 2001; Vanden Broeck, 2001 ). This putative peptide has been named differently in two independent studies: CAP2B/pyrokinin (Hewes and Taghert, 2001 ) and Drm-MT (Vanden Broeck, 2001) . Hugin is the second gene identified in the Drosophila genome that encodes a pyrokinin precursor (Choi et al., 2001 ; this study). To follow the nomenclature of the FXPRLamide family (Holman et al., 1986) , we named the hugin pyrokinin Drm-PK-2.
The synthetic Drm-PK-2 peptide displayed a moderate myostimulatory activity in the heterologous hyperneural muscle assay, which is routinely used for comparison of pyrokinin effects on muscle contractions (Predel and Nachman, 2001 ). The efficacy of the Drm-PK-2 peptide in the hyperneural muscle assay was similar to that of Pea-PK-3. The Drosophila pyrokinin also displayed cardiotropic activity in Drosophila itself, which suggests that specific pyrokinin receptors may occur in visceral muscles of the fruit fly. So far, only a single peptide, CCAP (crustacean cardioactive peptide), has been shown to stimulate Drosophila heart beat (Nichols et al., 1999) .
The other peptide, hugg, resembles the ecdysis-triggering hormone of D. melanogaster (Park et al., 1999) (Fig. 1C) . The invariant phenylalanine found in the C-terminal FXPRL-amide structure of pyrokinins, PBANs and diapause hormones is missing in the hugg peptide. The observed weak myomodulator activity of the peptide probably represents a typical cross-reaction of the PRL-amide peptides in various bioassays (see Gäde et al., 1997) . Due to the difficulty in attributing a precise role to this peptide, we leave the naming open until further data have been obtained.
The hugg and Drm-PK-2 peptides are most likely amidated in vivo and thus belong to the large PRL-amide family of insect neuropeptides which include pyrokinins, diapause hormones, pheromone biosynthesis activating neuropeptides (PBANs) and ecdysis-triggering hormones (reviewed in Gäde et al., 1997) . The site of expression of hugin mRNA in the suboesophageal ganglion is typical for many peptides of this family (Choi et al., 2001; Duportets et al., 1999; Predel and Eckert, 2000; Sato et al., 1993) . The ecdysis-triggering hormones are exceptional, being expressed in the peritracheal Inka cells (Ž itňan et al., 1996; Park et al., 2002) .
Ectopic expression unveils a molting defect
The function of the hugin gene was analysed through ectopic expression, since no mutants were available. In other insects, injections of extracts or peptides into living animals have revealed biological functions for several peptides belonging to the FXPRL-family of neuropeptides (reviewed in Gäde et al., 1997) . Ectopic expression in Drosophila using the UAS-GAL4 system mimics injections, but avoids the trauma caused by the injection needle. However, in the case of hugin, ubiquitous ectopic expression using the tubulin promoter causes potentially all peptides that are encoded by the gene to be present simultaneously depending on proteolytic processing. This may give rise to several overlapping physiological effects.
Ectopic hugin expression induced larval death almost exclusively at or shortly after ecdysis. This suggests that at least one peptide encoded by the hugin gene is able to interact with the neuropeptide signalling pathway involved in the ecdysis process. Ecdysteroids are required for the initiation of the events leading to ecdysis, while the ecdysis behaviour itself is regulated by the neuropeptides. In Drosophila, double mouth hooks on larval corpses are considered to be the hallmark of failed ecdysis. Among the described mutants having the double mouthpart phenotype, many have defects in genes involved in ecdysone synthesis (Henrich et al., 1993; Freeman et al., 1999; Venkatesh et al., 2001) or signaling (Hewes et al., 2000; Li and Bender, 2000; Yamada et al., 2000) . Failed ecdysis is also caused by mutations in genes encoding neuropeptide-processing enzymes (Jiang et al., 2000; Gooding et al., 2000) . Recently, mutants lacking the ETH gene were described. The ETH mutants exhibited an abnormal ecdysis behaviour, which often resulted in larvae that only partially managed to escape through an opening in the old cuticle, and which failed to detach their mouth hooks (Park et al., 2002) . The same phenomenon was seen in larvae with ectopic hugin expression (Fig. 5C ).
Premature induction of ecdysis behaviour was induced by injection of Drm-ETH-1 and results in failed ecdysis, where the animals become trapped in the old cuticle (Park et al., 2002; Ž itňan et al., 1996 . Hence, the absence as well as the presence of ETH at inappropriate time causes death through premature induction of the ecdysis behaviour. Ectopic hugin could likewise interfere with the ecdysis process, either through induction or inhibition of the ecdysis-signaling cascade. Indeed, the hugg peptide has primary sequence resemblance to Drm-ETH-1 (Fig. 1C) and could possibly be responsible for premature induction of ecdysis behaviour leading to the death of the larva. It has been experimentally shown that in addition to inducing factors, also inhibiting factors present in the suboesophageal ganglion play an important role during the ecdysis process (Ž itňan and Adams, 2000), although such an inhibiting factor still remains to be identified. Either of the peptides encoded by hugin could be such a factor. However, further analyses are required to discriminate between the functions and the individual peptides in vivo.
A substantial proportion of the larvae died as young third instar larvae. This could be explained with reference to defects that arise during larval development due to prematurely induced but still successful ecdysis, the consequences of which are not fatal until after the molt. Another possibility is that a badly timed myostimulatory effect during normal ecdysis causes problems, which later kill the larva. Abnormal ecdysis can bring along several problems, for example in feeding and respiration, which could be the ultimate cause of death (Park et al., 2002) . Death could also be the consequence of cuticular defects. Our observations of necrotic patches in the larval cuticula (Fig. 5D ) support this option. Less severely affected animals were able to complete ecdysis, but nevertheless died, maybe because the new cuticle did not sustain life. Previously, cuticular defects have been suggested to be the cause of death at the double mouth hook stage in larvae with ectopic FTZ-F1 expression (Yamada et al., 2000) and in larvae mutant for the sas cell surface receptor (Schonbaum et al., 1992) . A more direct link between cuticular defects and failed ecdysis has been demonstrated in an experiment where a chitin-synthesis inhibitor was fed to the larvae (Wilson and Cryan, 1997) . Finally, it seems that hugin overexpression does not simply operate through the ecdysis control pathway. Eventually, hugin lack-of-function mutants will need to be created and analysed in order to establish the roles of the gene.
Experimental procedures
4.1. Low stringency southern hybridisation of genomic DNA with a human glial cell line-derived neurotrophic factor probe Low stringency hybridisation was done on wild-type D. melanogaster genomic DNA (Oregon R) with a [a-32 P] dCTP-labelled human GDNF full-length cDNA probe at 378C for 16 h in a solution consisting of 43% formamide, 5 £ SSC, 1 £ Denhardt's, 0.3% SDS and 100 mg/ml denatured salmon sperm DNA. After hybridisation, the filter was washed twice for 15 min in 2 £ SSC, 0.1% SDS at 508C.
Library screening
A D. melanogaster genomic cosmid library was screened in pools using a human GDNF cDNA probe at low stringency conditions. Eventually, the EcoRI restriction fragment giving a positive hybridisation signal was subcloned from the cosmid into the pBluescript II KS-vector (Stratagene) resulting in the pXM1 plasmid.
A D. melanogaster l-ZAPII cDNA library (0-22 h after egg laying) kindly provided by Jan Larsson (Umeå) was screened at high stringency with a [a-
232 P]dCTP-labelled pXM1 probe. The isolated clone was modified by in vivo excision from the phage to a pBluescript II KS-vector, resulting in pXM1-cDNA.
RNA extraction and Northern analysis
Total RNA from all developmental stages was isolated with TRIzol Reagent according to the manufacturer's instructions (Life Technologies). The RNA was separated on a 1.2% formaldehyde agarose gel, transferred to filter and subjected to hybridisation with a [a-232 P]dCTP-labelled pXM1 probe under standard high stringency conditions. The equality of loading was controlled using an rp49 probe.
Sequencing and computer analyses
Sequencing was carried out by the chain termination method with an AutoRead sequencing kit (Pharmacia), and reaction products were analysed with an automated DNA sequencer (ALF, Pharmacia). Sequences were assembled using the gap4 program from the Staden package (Dear and Staden, 1991) . The sequences were analysed on the GCG package (Wisconsin Package Version 10, Genetics Computer Group (GCG), Madison, WI). Similarity searches were performed on the Web at EBI and NCBI. The hugin sequence was searched for motifs and compared to GDNF and related molecules using the MEME/MAST system (Bailey and Elkan, 1994) .
Whole mount in situ hybridisation
The expression pattern of hugin mRNA was detected by in situ hybridisation using a pXM1-cDNA probe according to standard protocols. As expression was observed in the suboesophageal ganglion until the latest embryonic stage, larvae were also collected and subjected to in situ hybridisation after their antero-ventral side was opened by microsurgery.
Construction of plasmids for expression
The pXM1-cDNA plasmid was used as a template for amplification of the wild-type gene (968C 30 s, 558C 45 s, 728C 1 min, 30 cycles) with the oligonucleotides ACTG-TTCGAAATCGCCACCGCACACTTGAGCACGTTTGC and ACTGGGTACCATGTGTGGTCCTAGTTATTGCA-CACTGC. The amplified fragment was cloned into the pMT/V5-HisB vector (Invitrogen). The resulting plasmid was named pMThugV5H6.
Expression in a Drosophila cell line
The Drosophila Schneider 2 (S2) cells were grown in Drosophila expression system (DES, Invitrogen) complete medium with 10% foetal calf serum (FCS) at 288C. For transfection, cells were seeded on 35 mm plates. Transient transfections were performed with Fugene 6 Transfection Reagent (Boehringer Mannheim) according to manufacturer's instructions. Stable cell lines were created according to Invitrogen's instructions. Conditioned media were collected 48-72 h after CuSO 4 induction.
Western blotting
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) gels were blotted on Hybond-C filter (Amersham). Detection of fusion proteins was performed with the ECL kit (Amersham) by anti-penta-His antibody (Qiagen) diluted 1:1500 followed by anti-rabbit HRP (DAKO) 1:3000 or alternatively by anti-V5 antibody (Invitrogen) diluted 1:5000 followed by anti-mouse HRP (DAKO) 1:2000.
N-terminal amino acid sequencing
Conditioned medium from S2 cells stably transfected with pMThugV5H6 was harvested and sterile-filtered. HEPES buffer was added to 20 mM before binding to TALON resin (Clontech). Binding and elution of Histagged molecules were performed according to manufacturer's instructions. A PD-10 column (Amersham Pharmacia) was used for salt removal. All the samples were lyophilised, dissolved in water and separated by SDS-PAGE and blotted on PVDF membrane (Millipore), wherefrom the bands were cut out and used for N-terminal amino acid sequencing by Edman degradation according to standard procedures.
Muscle bioassays
Peptides SVPFKPRL-NH 2 and LQSNGEPAYRVRTP-RL-NH 2 were synthesised (Sigma-Genosys, Cambridge, UK) and tested with the P. americana hyperneural muscle bioassay for pyrokinin activity as described elsewhere (Predel and Nachman, 2001 ). The Pea-PK-3 pyrokinin from P. americana was used as a positive control (Predel and Nachman, 2001) .
Additionally, semi-isolated heart preparations (dorsal part of the abdomen) of D. melanogaster (third larval instar) were placed in a temperature-controlled plexiglas chamber (258C) filled with sylgard resin and superfused with insect saline. Inflow and outflow were regulated with a multichannel peristaltic cassette pump, peptide applications were carried out via the tube of the peristaltic pump in the final dilution. The heart rate was measured by means of a microscope equipped with a photocell and light transmitting the preparation from below (Predel et al., 1999a) .
P-element germ-line transformation
The cDNA containing the full-length hugin coding sequence was cloned into the pUAST vector. The construct was transformed into white flies by standard P-element transformation. Five independent UAS-hugin lines were obtained, all viable as homozygotes. The insertion sites were determined on polytene chromosomes with in situ hybridisation (Heino, 1994) . One line carried two independent insertions on the second chromosome (UAS-hugin 8). This line was used for phenotypical analyses.
Fly strains and cultures
Several GAL4-driver lines were tested for effects of ectopic hugin expression. Eventually, only two of them were used for the analyses. One line carried the ubiquitous driver P{w 1mC ¼ tubP-GAL4}LL7 balanced over either TM3SbLacZ or TM3SerGFP. The other line carried a driver inducing GAL4 expression in the embryonic ventral nerve cord and neuroblasts (w 1 ;P{w 1mC ¼ GAL4}105.1). As a control, LacZ was ectopically expressed using the tubP-GAL4 driver, or then GAL4 was expressed alone in the same white background as was used for the transformations. Crosses were done at 298C; otherwise, the flies were raised at 258C.
For the determination of the larval lethal phase, eggs were collected for 4 h on apple juice egg-laying plates supplemented with yeast. Next day, the number of hatched and unhatched eggs was counted, and all fluorescent (heterozygous) larvae were removed in crosses involving tubP-GAL4/ TM3SerGFP. The remaining larvae were reared on the same plates supplemented with dry yeast. Dead larvae were removed daily, and the larval stage was determined based on mouth hooks and anterior spiracles (Roberts and Standen, 1998) .
The sequence reported in this paper has been deposited in the GenBank/EMBL/DDBJ database (accession no. AJ133105).
